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Objectives: Necrotizing enterocolitis (NEC) has been associ- 
ated with a wide variety of bacteria and their cytotoxins. The 
content and the nature of gut bacterial colonization in new- 
borns that require intensive care hospitalization has been 
demonstrated to be abnormal. In the 25bed neonatal inten- 
sive care unit in Hospital Simon Bolivar, in Bogota, Colombia, 
cases of NEC are common causes of morbidity and mortality. 
This article examines the hypothesis that oral administration of 
prophylactic Lactobacillus acidophilus and Bifidobacterium 
infantis to all neonates in an intensive care unit, would decrease 
the incidence of NEC. 
Methods: Daily doses of 250 million live L. acidophilus and 250 
million 5. infantis were given to all 1237 newborns (both in- 
patients and transfer patients) admitted to the unit during 1 year, 
until they were discharged from the hospital. In this study, 1282 
patients hospitalized during the previous year were used as 
controls. 
Results: There were no complications attributed to the daily 
administration of L. acidophilus and B. infantis. The study 
groups were compared for place of origin, clinical, and demo- 
graphic variables, and there was no statistically significant dif- 
ference in those variables. In the historic control group, there 
were 85 NEC cases compared to 34 cases in the group that 
received probiotic prophylaxis (P < 0.0002). In the historic con- 
trol group, there were 35 NEC-associated fatalities compared 
to 14 fatalities in the group that received probiotic prophylaxis 
(P < 0.005). 
Conclusions: The positive results in this study support the need 
for further investigation of bacterial colonization and its role in 
NEG. 
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Although the etiology of necrotizing enterocolitis (NEC) 
still is not clear, possible contributing factors include patho- 
genic bacteria, an imbalance of bacteria in the intestinal 
lumen, and barrier dysfunction. The fact that NEC does 
not occur in utero in spite of stress and fetal ingestion of 
150 mL/kg per day of amniotic fluid that contains pro- 
teins, carbohydrates, fat, immunoglobulins, and elec- 
trolytes suggests that bacteria are critical in the 
pathogenesis of this disease.lJ Animal experiments also 
have demonstrated the need for bacterial colonization in 
NEC.3-5 
Research examinin g the content and the nature of 
gut bacterial colonization in newborns that require inten- 
sive care hospitalization has demonstrated that coloniza- 
tion is abnormal. The appearance of heterogeneous 
microflora is both delayed and replaced by only a few 
species.6 A newborn that is colonized with aggressive 
and drug-resistant bacteria from the neonatal intensive 
care unit may be at greater risk for NEC or its com- 
plications. The use of oral antibiotics modifies gastro- 
intestinal microflora, but the risk for resistant bacteria 
overgrowth has discouraged its use.‘z8 Studies in adult 
transplants have demonstrated bacterial translocation 
with oral antibiotics.9-11 
The usefulness of biotherapeutic agents (micro- 
organisms with therapeutic properties) in gastrointestinal 
infections has been reviewed.12 It has been demonstrated 
that Lactobacillus acidophilus, by adequately adhering to 
the intestinal wall, can inhibit other pathologic bacte- 
ria 13-15 including Klebsiella pneumoniae and Candida 
allhcans,‘h~‘7 and the utilization of bifidobacteria to 
reduce NEC has been demonstrated in rats.i’ However, 
some trials to modify bacterial colonization by adminis- 
tering Lactobacillus and maintaining oral feedings during 
treatments with antibiotics in neonates have been suc- 
cessful in colonizing the gut with Lactobacillus, but with- 
out modifying the gram-negative resistant bacterial 
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colonization. l9 Nevertheless, the production of staphylo- 
cocci and Clostridium difsicile endotoxins or the pres- 
ence of gram positive bacteria in these settings is 
unknown. This induced colonization has not been eval- 
uated in relation to the incidence of NEC. 
Probably secondary to the lack of staff and resources, 
cases of NEC occurred frequently in the newborn unit of 
Hospital Simon Bolivar, a public university hospital in the 
city of Bogota. These cases were associated with serious 
outcomes, including fatalities. The NEC cases typically 
occurred in small clusters; initial interventions with anti- 
biotic treatments and temporary isolation measures in 
the unit partially controlled them. However, the clusters 
of NEC soon returned. An alternative approach was devel- 
oped with the hypothesis that modifying the intestinal 
microflora colonization of all the newborns in the unit 
would decrease the incidence of NEC. 
METHODS 
Setting 
Hospital Simon Bolivar is the only third level referral pub- 
lic university hospital for the poor northwest section of 
the city, and northern part of the state. Nevertheless the 
hospital receives patients from the entire state. The 
neonatal intensive care unit is a 25-bed unit grouped into 
three sections (intensive care, intermediate care, and min- 
imal care) that are not physically divided. 
Population and Microorganism Administered 
The probiotic agent, Infloran Berna (Swiss Serum and 
Vaccine Institute Berne, Berne, Switzerland) that con- 
tained 1000 million live L. acidophihs and 1000 million 
Bifidobacterium infantis per capsule was used. All new- 
borns (both inpatients and transfer patients) admitted to 
the unit during 1 year (October 15,1994, to October 15, 
1995) received prophylactically one-quarter capsule of 
probiotic agent dissolved in 1 mL of sterile water or 5% 
dextrose daily during their entire hospital stay This group 
is designated probiotic group (PG). If the patient could 
suction and swallow, the preparation was put directly on 
the mouth drop by drop, otherwise it was given by oro- 
gastric tube. If the newborn had a gastrointestinal prob- 
lem that required decompressive gastric tube, the 
stomach was emptied, the preparation was introduced 
through the tube, the neonate was put in a right lateral 
position, and the tube was closed for 1 to 3 hours, accord- 
ing to the tolerance for this closure. All neonates were 
observed carefully for any signs or symptoms attribut- 
able to the use of the preparation. Stool color and con- 
sistency was evaluated to assess tolerance. Patients 
hospitalized during the previous year (October 15, 1993 
to October 15, 1994) were used as the control group 
(designated as no-probiotic group: no-PG). 
The study was approved by the Research Committee 
of the Hospital Simon Bolivar. Informed consent was 
obtained from the parents or guardians. 
Definition of Necrotizing Enterocolitis 
A case of NEC was defined as a patient with at least one 
gastrointestinal, one systemic, and one radiographic para- 
meter of the following: 
Gastrointestinal criteria: 
1. Abdominal distention or tenderness 
2. Feeding intolerance that consisted of presence or 
increase in the gastric aspirates (residues of more 
than 30% of the administered milk) or persistent 
emesis 
3. Stools with occult or gross blood 
4. Diarrhea and erythema of abdominal wall accompa- 
nied by systemic signs and symptoms, including (a) 
lethargy, (b) apnea or respiratory distress, (c) tem- 
perature or glucose instability, (d) poor perfusion or 
shock, (e) disseminated intravascular coagulation, or 
(f) positive blood cultures that were not present 
before the gastrointestinal signs and symptoms. 
Radiologic criteria: 
1. Dilated bowel loops (as compared with the first lum- 
bar vertebra) 
2. Bowel wall thickening 
3. Intraperitoneal fluid 
4. A single persistent dilated loop 
5. Pneumatosis intestinalis 
6. Portal vein gas 
7. Pneumoperitoneum. 
The fmal determination of the diagnosis of NEC was made 
by a small group of attending physicians that did not 
change during the study years. If the attending physician 
at the end of the course considered there was sufficient 
evidence of NEC, the case was included in the study; if, 
on the contrary, the physician thought there was not 
enough evidence it was not included. Both suspected 
and confirmed NEC were included in both groups. 
Feeding Protocol 
There is a strict feeding protocol with daily fixed increases 
that existed in the unit prior to the study and was main- 
tained equally in the 2 years of the study. Depending on 
the birth weight and gestational age, a fmed amount per 
kilogram of half strain milk is initiated after one or two 
trials with still water. It is advanced, if tolerated, with slow 
careful increases. If there is any sign of intolerance it is 
immediately stopped. Most premature infants under 
1500 g receive total parental nutrition prior to and dur- 
ing advancement until full feedings are tolerated. 
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The group of physicians in charge of the patients 
were not modified except by the rotation of residents 
who follow established protocols in the unit. Neither the 
nursing nor the other support staff in the unit were 
changed during the study period or the year before. There 
were no modifications in any managing protocols, clini- 
cal practices, equipment, infrastructure, or any other ele- 
ments in the unit that could have produced changes in 
the probiotic group compared with the previous year. 
Data Collection 
During the 2 years of the study, data collection was done 
by completing a surveillance record at the time of dis- 
charge that included 280 different clinical and demo- 
graphic variables of general epidemiologic information 
as well as specific information regarding the patient’s 
condition. 
Statistical Analysis 
Data were entered into a personal computer by using 
SAS (version 6.0 SAS Institute Inc. 6.0) (SAS Campus 
Drive, Cat-y, North Carolina). Logistic regression analysis 
was used to assess whether the independent variable 
studied (probiotic group) correlated with NEC or asso- 
ciated mortality. Patient demographic, clinical, illness, and 
probiotic group characteristics (e.g., sex, maternal age, 
parity, birth weight, gestational age, Apgar scores, other 
infections, different treatments) were covariates. Inde- 
pendent risk factors for NEC were examined in both pop- 
ulations for confounding and interacting variables. The 
Student’s t-test and the Mann-Whitney test for nonpara- 
metric variables also were used. A value of P < 0.05 was 
considered statistically significant. Patients born in the 
institution were compared both together and separately 
from patients born in other hospitals and transferred. 
RESULTS 
A total of 1237 newborns received one-quarter capsule 
of the probiotic agent preparation daily; approximately 
9000 doses were administered during the study The first 
modification observed was a change in color of the stools 
from assorted coffee and green tones to light yellow in 
most of the newborns receiving the preparation. 
The study groups were compared for place of ori- 
gin, demographic and clinical variables (Tables 1 and 2). 
Owing to the length of the results, the full demographic 
data are not presented. The only statistically significant dif- 
ference among these variables was that there were fewer 
babies in the probiotic group in the 2000- to 2499-g 
weight category. There also were more babies in the pro- 
biotic group under 1500 g; however, this did not reach 
statistical significance. 
Table 1. Comparison of Study Groups by Place of Origin 
Study Group 
Inpatient 
Transfer 
Readmission 
Without data 
No-Probiotics Probiotics 
n = 1282 (%j n = 1237 (96) 
935 (72.9%) 918 (74.2%) 
261 (20.4%) 238 (19.2%) 
64 (5.0%) 46 (3.7%) 
22 (1.7%) 35 (2.8%) 
P 
NS 
NS 
NS 
NS 
The incidence of NEC in inpatients treated with pro- 
biotic prophylaxis was reduced to one-third of the num- 
ber of cases in the control group (18 vs. 47 cases; 
P < 0.0005), and the transferred patients who were 
treated had less than half the number of cases seen in the 
untreated group (19 vs. 38; P < 0.03) (Table 3). The 
decrease in inpatient NEC-associated mortality was even 
greater with a decrease from 25 to 7 cases. The incidence 
of NEC was predominantly in infants with low birth 
weight in both the probiotic group and the no-probiotic 
group (65% vs. 69%). The average weight (2040 g vs. 
2048 g) and gestational age (35 weeks in both) were sim- 
ilar in the two groups. The inpatients that developed NEC 
were smaller than the transfer patients (32% vs. 79% 
above 2000 g) and less mature (25% vs. 48% over 36 
weeks gestational age) in the no-probiotic group, but they 
were similar in weight and maturity in the probiotic 
group (50% and 53% above 2000 g and 26% vs. 33% over 
36 weeks gestational age). 
All cases of NEC in 1994 (no-PG) with intestinal per- 
foration secondary to NEC died (6/6), five were inpatients 
and one was a readmission. In 1995 (PG), two inpatient 
cases with intestinal perforation secondary to NEC died, 
the first case secondary to septic shock and coagulopa- 
thy and the second case 45 days later secondary to intesti- 
nal complications. 
All patients with NEC with perforations had surgery 
during both years. Sometimes it was to place a drain, 
owing to poor prognosis. All cases with NEC had sys- 
temic antibiotics for at least 10 days if they survived. No 
oral antibiotics were used in either year. 
No complications attributed to the use of the pro- 
biotic preparation were observed. It is interesting to note 
the unanimous consensus among the neonatal intensive 
care unit staff that there was an improvement in feeding 
tolerance and diaper dermatitis with and without Cun- 
dida albicans infection; however this parameter was not 
consistently recorded during 1994 (no-PG); therefore, it 
remains only a general observation. During 2 months in 
the PG period, there was an increase in systemic can- 
didiasis in patients who received extended antibiotics, 
including three of the patients with intestinal perforation. 
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Table 2. Description of Study Population 
Average hospital stay (d) 
Average birth weight (g) 
Less than 1000 g 
1000-1499 g 
1500-l 999 g 
2000-2499g 
2500-4000g 
More than 4000 g 
No data 
Average gestational age (wk) 
Less than 28 wk 
28-32 wk 
33-34 wk 
35-36 wk 
37-40 wk 
41-42 wk 
More than 42 wk 
No data 
1 minute Apgar scores 
Average 
Less than 4 (%) 
4-6 (%) 
More than 6 (%) 
Without data (%) 
5 minute Apgar scores 
Average 
Less than 4 (%) 
4-6 (%) 
More than 6 (%i 
Without data‘(%) 
Twins 
Sex 
Male (%) 
Female (%) 
No data (%) 
Ambiguous (%) 
Meningitis 
Pneumonia 
Sepsis 
Treatments 
Total parenteral nutrition 
Antibiotics 
Surgery (gastrointestinal) 
Plasmapheresis 
Assistant ventilation 
General mortality 
No-T 
n = 935 (%) 
Inpatient 
PG 
n = 918 (%) P 
No-PG 
n = 347 (%) 
Transfer 
PG 
n=319(%) P 
5.5 5.6 
2594 2600 
20 (2) 22 (2) 
43 (5) 58 (6) 
127 (14) 118 (13) 
245 (26) 198 (21) < 
460 (49) 485 (53) 
38 (4) 42 (5) 
2 (0) 4 (0) 
173i2) 213;2, 
101 (11) 33 (9) 
90 (10) 78 (8) 
88 (9) 99 (11) 
415 (44) 450 (49) 
138 (15) 119 (13) 
12 (1) 9 (1) 
75 (8) 59 (6) 
a37(9, 
156 (17) 
652 (70) 
45 (5) 
76’(8) 
159 (17) 
628 (68) 
55 (6) 
8 
23 (2) 
88 (9) 
781 (83) 
44 (5) 
61 
l3g(l) 
73 (8) 
776 (85) 
56 (6) 
58 
503 (50) 
427 (50) 
4 (0) 
2 (0) 
2 
37 
39 
507 (55) 
400 (44) 
8 (1) 
3 (0) 
a 
34 
36 
82 80 
229 245 
11 17 
44 65 
69 73 
98 93 
NS 
NS 
NS 
NS 
NS 
0.05 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
8.5 
2630 
0 (0) 
19 (5) 
38 (11) 
81 (23) 
188 (54) 
17 (5) 
4 (1) 
33;) 
26 (8) 
20 (6) 
23 (7) 
131 (38) 
22 (6) 
2 (1) 
120 (35) 
8.5 
2746 
2 (1) 
14 (4) 
43 (13) 
46 (14) 
1 a7 (59) 
19 (6) 
8 (2) 
37 
1 (0) 
17 (5) 
19 (6) 
32 (10) 
121 (38) 
22 (7) 
2 (1) 
105 (33) 
1 47(4) 
30 (9) 
113 (33) 
190 (55) 
6 (3) 
25 (8) 
102 (32) 
184 (58) 
371) 2h 
13 (4) a (3) 
136 (39) 121 (38) 
195 (56) 187 (59) 
19 22 
188 (54) 186 (58) 
156 (45) 118(37) 
3 (1) 15 (5) 
5 2 
89 90 
31 38 
58 
166 
20 
16 
34 
42 
51 
151 
16 
13 
34 
44 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
*Statistically significant; NS = statistically nonsignificant. 
The evolution of all the cases was satisfactory. Cundida 
albicans was cultured from one of the total parenteral 
nutrition equipment sets. 
Whereas there were frequent NEC clusters during 
1994, there were only two clusters with gastrointestinal 
disease during 1995, which began in patients from an 
adoption house who had diarrhea as the original symp- 
tom, and were probably of viral origin. The first cluster 
only had two cases. The first case did not have NEC, only 
diarrhea, but a patient in an adjacent bed space did 
develop NEC. Several months later, another cluster of 
gastrointestinal disease, involving eight patients, began 
with a neonate from the same adoption house who had 
diarrhea. The infant died a few hours later of septic shock 
and intestinal perforation. This diarrhea epidemic lasted 
2 weeks, but there were no further cases of NEC. 
Although these clusters were probably of viral origin, it 
was not possible to obtain microbiologic confirmation, 
because of lack of viral culture and other viral identifi- 
cation techniques. There were no positive bacterial blood 
cultures in any case during those clusters in 1995. 
As an observation, the use of the probiotic prepara- 
tion was continued in the unit after the study was fin- 
ished, but secondary to administrative difficulties, 5 
months later this protocol was stopped. Soon after, the 
enterocolitis returned, and there were several fatalities. 
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Table 3. Incidence of Necrotizing Enterocolitis in Probiotic-Treated Neonates and Controls 
Number of Cases with NEC 
No-Probiotic Probiotic P-Value 
Patient origin 
Inpatient 
Transfer 
Patients with NEC number admitted (%) 
Necrotizing enterocolitis-associated mortality 
Inpatient 
Transfer 
*Statistically significant: NS = statistically nonsignificant. 
85 37 <0.0002* 
47 18 <0.0005* 
38 19 <0.03* 
6.63 2.99 
35 14 <0.005* 
25 7 <0.004* 
10 7 NS 
CONCLUSIONS 
1. There were no complications attributed to the daily 
oral administration of 250 million L. acidophilus and 
250 million B. infantis. 
2. In neonatal intensive care units with limited staff and 
resources and frequent epidemics of NEC, system- 
atic use of daily oral prophylactic L. acidophilus and 
B. infantis may partially or totally control these clus- 
ters, reducing cases of NEC and associated mortality 
3. This project raises the casual observation of im- 
proved oral feeding tolerance and decreased inci- 
dence of diaper dermatitis with and without candidal 
infection in patients receiving Infloran, that needs 
further study. 
Although positive results were expected, the disap- 
pearance of NEC in its cluster form was a surprise. The 
gastrointestinal clusters in 1995 during the administra- 
tion of the preparation looked more like a viral infection 
brought from the adoption house than classic NEC. More 
mature and larger babies in this study developed NEC 
compared with the usual tiny babies who developed NEC 
in the United States. Probably this has to do with the 
larger average weight of the entire unit popul.ation in 
Bogota, the percentage of fewer tiny survivors, as well as 
the inadequate conditions that exposes more mature 
babies to intestinal colonization with aggressive resistant 
bacteria in Bogota. 
Many infants required plasmapheresis, because 
Bogota is 8500 feet above sea level and polycythemia is 
common. This was done peripherally without umbilical 
catheterization. In fact, umbilical catheters were rarely 
used, and none of the babies that developed N:EC were 
umbilically catheterized. Central lines were common, all 
of them via jugular vein. This procedure was performed 
equally in both groups. 
Systematic gastrointestinal cultures were not done 
during the study. Twenty-five infants who received the 
probiotic agent for at least 5 days were cultured after the 
study, including 10 of them who received systemic anti- 
biotics. Most of them were colonized with L. acidophilus 
or B. infantis, and there was no difference if they were 
receiving systemic antibiotics, probably because of daily 
administration of new preparation each morning. Among 
other microflora 3 of 25 babies also were colonized with 
E. coli and none with Klebsiella. There is some incom- 
plete information on colonization of some babies with 
Klebsiella, who developed severe NEC with sepsis both 
in 1994 and 1995. Klebsiella, which usually is resistant to 
most common antibiotics, is an endemic bacteria in sev- 
eral units in crowded public hospitals in Bogota, includ- 
ing Hospital Simon Bolivar. Unfortunately incomplete data 
are available for 1994, precluding any comparison. 
The complexity of the pathology in NEC has gener- 
ated a large number of possible interventions that are dif- 
ficult to evaluate with strict scientific rigor. This is not 
a double-blind placebo-controlled study. This methodol- 
ogy was designed to obtain groups that are comparable, 
with the only difference being the intervention. Fortu- 
nately, the two groups in this study are comparable, as the 
statistical analysis of a large number of variables indicates. 
The positive results in this study highlight the need for 
further investigation into bacterial colonization and its 
role in NEC. Several questions emerge as a result of this 
study. If the alteration of gastrointestinal flora by the 
administration of supplements is useful in neonatal inten- 
sive care units with limited resources, is it also useful for 
units with much better control of nosocomial infections? 
Furthermore, although prior studies indicate that ade- 
quate colonization by nonpathogenic bacteria might 
improve the tolerance to oral feeds and avoid “luminal 
starvation:’ this must be documented in adequately con- 
trolled studies. 
Speculation 
Despite the theoretic benefits of inducing colonization 
with nonpathogenic bacteria in neonates, there has been 
resistance to administering microorganisms to neonates. 
Consequently, it has been difficult to study these types of 
interventions in newborn intensive care units with suf- 
ficient patients and a variety of microorganisms. How 
does altering gut colonization decrease NEC? The eco- 
logic principle of an adequate balance of the live organ- 
isms may be applicable. The replacement of resistant and 
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aggressive bacteria with nonpathogenic strains in total 
number of organisms as well as possibly reducing the 
toxin-producing strains may be one of the principle 
mechanisms. Alternatively, there may be a more complex 
interaction with a combination of several types of 
microflora that modify the adherence or invasiveness of 
the possible causative organisms of NEC.20 However, it 
also is plausible that the type of gut colonization of the 
newborn is a determinant of the intensity of the inflam- 
matory processes that can be produced by the inter- 
action of bacteria with the oral feedings. 
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